• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    IFIC 2022 Food & Health Survey Highlights Eating Behavior Trends

    Icon Foods Appoints Operations and Marketing Leaders

    Annatto Tocotrienol Shown to Improve Weight Loss and Inflammation Markers in Patients with NAFLD

    GC Rieber VivoMega Continues to Find Operational Efficiencies, Minimize Environmental Impact

    Vitamin A Deficiency: 53% of Primary School Children in Rural Malaysia Found to be Malnourished
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Icon Foods Appoints Operations and Marketing Leaders

    Annatto Tocotrienol Shown to Improve Weight Loss and Inflammation Markers in Patients with NAFLD

    GC Rieber VivoMega Continues to Find Operational Efficiencies, Minimize Environmental Impact

    Vitamin A Deficiency: 53% of Primary School Children in Rural Malaysia Found to be Malnourished

    PLT to Supply Traceable, Standardized Organic Elderberry Extract
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    IFIC 2022 Food & Health Survey Highlights Eating Behavior Trends

    Icon Foods Appoints Operations and Marketing Leaders

    Annatto Tocotrienol Shown to Improve Weight Loss and Inflammation Markers in Patients with NAFLD

    Vitamin A Deficiency: 53% of Primary School Children in Rural Malaysia Found to be Malnourished

    PLT to Supply Traceable, Standardized Organic Elderberry Extract
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Annatto Tocotrienol Shown to Improve Weight Loss and Inflammation Markers in Patients with NAFLD

    Vitamin A Deficiency: 53% of Primary School Children in Rural Malaysia Found to be Malnourished

    PLT to Supply Traceable, Standardized Organic Elderberry Extract

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    Atlantia Clinical Trials

    Sabinsa Corporation

    KLK OLEO
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    Atlantia Clinical Trials

    Sabinsa Corporation

    KLK OLEO
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Lesaffre Gains Health Claim for ibSium Ingredient in Canada

    Yeast strain helps to reduce abdominal pain and discomfort associated with IBS.

    Related CONTENT
    • Gnosis, Now Acquired by Lesaffre, Announces New Business Strategy
    • Lesaffre to Highlight Ingredients for Women’s Health
    • Lesaffre Human Care Launches Yeast Protein Line
    • Lesaffre Human Care to Introduce LifeinU Bacillus subtilis CU1
    • Lallemand to Unveil Innovative Probiotics for the Gut-Brain Axis
    09.22.15
    Canadian Health Authorities have granted Lesaffre Human Care a health claim for its ibSium yeast strain in connection with relief of symptoms associated with irritable bowel syndrome (IBS).

    Based on the findings of a first clinical trial, which were recently published in the journal Digestive and Liver Disease, Health Canada has granted Lesaffre Human Care a new condition-specific claim for ibSium, the company’s unique strain of Saccharomyces cerevisiae CNCM I-3856. The newly approved claim is as follows: “Helps to reduce abdominal pain and discomfort associated with irritable bowel syndrome (IBS).”

    ibSium has been exclusively licensed to Medical Futures Inc. (MFI), a wholly owned subsidiary of Tribute Pharmaceuticals Canada Inc., for the Canadian market. MFI will launch a finished product also called ibSium in Canada in the coming months.

    Obtaining this new health claim is a big win for Lesaffre Human Care; it is a recognition of the company’s long-term investment in providing strong scientific and clinical data to substantiate the benefits of its patented strain of Saccharomyces cerevisiae in individuals with irritable bowel syndrome. The ingredient, also known on the market as Lynside Pro GI+ in certain countries, has demonstrated a significant effect in improving abdominal pain and discomfort in individuals with IBS, through:

    Two clinical studies on a total of 600 volunteers with IBS and conducted by independent experts in Gastroenterology,

    One consumer study implemented in collaboration with prescribing physicians on more than 1,160 volunteers presenting symptoms of IBS.

    Sandrine Cuisenier, global marketing manager for Lesaffre Human Care, explained that “with millions of people worldwide affected by IBS, many of them unsatisfied with their current treatment, this claim approval will definitely have a positive impact on sales. It strengthens the position of our customers on the market by allowing end-users to better grasp the real benefits that ibSium could have on their quality of life. As an ingredient supplier, obtaining a strong label also builds trust and confidence in the quality of our products and the associated scientific research, a way for Lesaffre Human Care to reiterate its commitment to providing the highest level of service and product excellence.”

    For people looking for a long-term strategy to manage their intestinal pain and discomfort, ibSium, now approved by Health Canada, will be soon available as an all-natural health solution in Canada, as it is already in some other countries. ibSium is a safe and effective new answer that helps to reduce abdominal pain and discomfort associated with irritable bowel syndrome, according to the company.
    Related Searches
    • Health
    • Digestive Health
    • Natural
    • Regulations
    Related Knowledge Center
    • Digestive Health
    • Research
    • Regulations
    Suggested For You
    Gnosis, Now Acquired by Lesaffre, Announces New Business Strategy Gnosis, Now Acquired by Lesaffre, Announces New Business Strategy
    Lesaffre to Highlight Ingredients for Women’s Health Lesaffre to Highlight Ingredients for Women’s Health
    Lesaffre Human Care Launches Yeast Protein Line Lesaffre Human Care Launches Yeast Protein Line
    Lesaffre Human Care to Introduce LifeinU Bacillus subtilis CU1 Lesaffre Human Care to Introduce LifeinU Bacillus subtilis CU1
    Lallemand to Unveil Innovative Probiotics for the Gut-Brain Axis Lallemand to Unveil Innovative Probiotics for the Gut-Brain Axis
    Oralis SB Granted Oral Health Claim in Canada Oralis SB Granted Oral Health Claim in Canada
    Lesaffre Debuts New Probiotic Range Lesaffre Debuts New Probiotic Range
    Lesaffre Human Care Spotlights Immune Health Lesaffre Human Care Spotlights Immune Health
    ibSium Helps Reduce Irritable Bowel Syndrome Symptoms ibSium Helps Reduce Irritable Bowel Syndrome Symptoms
    Verisol Approved by Health Canada Verisol Approved by Health Canada
    RIBUS Expands Management Staff RIBUS Expands Management Staff
    Lesaffre Probiotic Yeast Found to Alleviate IBS Pain Lesaffre Probiotic Yeast Found to Alleviate IBS Pain
    Pharmavite Acquires Whole Food Supplement Developer FoodState Pharmavite Acquires Whole Food Supplement Developer FoodState
    Naturex Receives Natural Product Number for Svetol in Canada Naturex Receives Natural Product Number for Svetol in Canada
    Health Canada Approves Sales of Relora in Canada Health Canada Approves Sales of Relora in Canada

    Related Breaking News

    • Breaking News | Dietary Supplements | Functional Foods & Beverages | Immune Function | Mergers & Acquisitions | Mood Health & Sleep | Probiotics & Prebiotics | Sports Nutrition | Supplier News | Women's Health | World Markets
      Gnosis, Now Acquired by Lesaffre, Announces New Business Strategy

      Gnosis, Now Acquired by Lesaffre, Announces New Business Strategy

      The company’s product development specialization centers around biotransformation processes.
      10.08.20

    • Lesaffre to Highlight Ingredients for Women’s Health

      Company offers product range backed by strong science.
      05.08.17

    • Proteins, Peptides, Amino Acids | Supplier News

      Lesaffre Human Care Launches Yeast Protein Line

      Lynside ProteYn provides nutritional support for those interested in non-animal sources of protein.
      11.28.16


    • Lesaffre Human Care to Introduce LifeinU Bacillus subtilis CU1

      The company will focus on immune health with the introduction of its highly stable probiotic.
      10.05.16

    • Lallemand to Unveil Innovative Probiotics for the Gut-Brain Axis

      Company will highlight its range of solutions for targeted consumer groups.
      10.03.16

    Loading, Please Wait..
    Trending
    • Evolution Nutraceuticals To Discontinue Challenged Claims For ‘Cardio Miracle’ Dietary Supplement
    • Vitamin K2 Status May Impact Blood Pressure And Pulse Wave Velocity
    • Zeus Hygia Launches Muscle Recovery Ingredient, Gremin
    • Study Examines Vitamin K2 Content In Cheese
    • Chenland Nutritionals Self-Affirms GRAS For Cumin UP60 Ingredient
    Breaking News
    • IFIC 2022 Food & Health Survey Highlights Eating Behavior Trends
    • Icon Foods Appoints Operations and Marketing Leaders
    • Annatto Tocotrienol Shown to Improve Weight Loss and Inflammation Markers in Patients with NAFLD
    • GC Rieber VivoMega Continues to Find Operational Efficiencies, Minimize Environmental Impact
    • Vitamin A Deficiency: 53% of Primary School Children in Rural Malaysia Found to be Malnourished
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    IFIC 2022 Food & Health Survey Highlights Eating Behavior Trends
    Icon Foods Appoints Operations and Marketing Leaders
    Annatto Tocotrienol Shown to Improve Weight Loss and Inflammation Markers in Patients with NAFLD
    Coatings World

    Latest Breaking News From Coatings World

    Birla Carbon, NREL Collaboration to be Presented at ACS Conference
    Coating Resins Market Worth $70.9 Billion by 2027: MarketsandMarkets
    PPG Appoints Brad Budde Vice President and Chief Digital Officer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    EchoNous Partners with Samsung
    Solid Growth Forecast for Global Ostomy Devices Market
    KA Imaging's Reveal 35C Images Increase Lung Lesion Visibility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    GRAM to Fill and Finish Smallpox/Monkeypox Vaccines
    bluebird bio Wins FDA Approval of ZYNTEGLO
    Pace Life Sciences Acquires Meridian BioGroup
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Sephora at Kohl’s to Expand Sephora Presence to All 1,100+ Kohl’s Locations
    Emma Watson to Front New Fragrance Campaign for Prada
    The Estée Lauder Companies Delivers Strong Results in Fiscal 2022
    Happi

    Latest Breaking News From Happi

    Amorepacific, MIT Develop World's First Chip-less Wireless Electronic Skin Enabled by Semiconductors
    Maesa Launches Itk Skincare with TikTok Stars Brooklyn and Bailey McKnight
    Skin Delivery Formulation
    Ink World

    Latest Breaking News From Ink World

    Xeikon to Introduce TITON Food-Safe Dry-Toner Technology at Labelexpo Americas 2022
    Smurfit Kappa Employees Charity Cycle Across Europe
    ProAmpac’s Rocky Mount, VA Facility Receives ISCC Plus Certification
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ePac makes big announcement, Avery Dennison debuts new technology and more
    Techkon USA announces latest handheld spectrodensitometer
    Maxcess China now manufacturing solid dies in Huzhou
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    INDA Appoints Director of Membership and Industry Relations
    Nexwear Acquires Incontinence Products Brand Lily Bird
    Because Market Expands into Retail Stores
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Theragen Receives Patent for Spine Fusion Bone Growth Stimulator System
    Study: BONESUPPORT’s CERAMENT G Can Help Save Infected Limbs
    Zavation’s Cervical Intervertebral Body Fusion Device Cleared by FDA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    NREL, Birla Carbon Collaboration to be Shown at ACS Conference
    ORNL Celebrates Launch of Frontier, the World’s Fastest Supercomputer
    DuPont Names 2022 Lavoisier and Pedersen Award Medalists

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login